Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) Other Non Operating Income: 2010-2025

Historic Other Non Operating Income for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $7.3 million.

  • Exponent's Other Non Operating Income fell 3.51% to $7.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $16.7 million, marking a year-over-year decrease of 36.12%. This contributed to the annual value of $17.8 million for FY2025, which is 2.23% up from last year.
  • Exponent's Other Non Operating Income amounted to $7.3 million in Q4 2025, which was down 57.98% from $17.3 million recorded in Q3 2025.
  • Exponent's 5-year Other Non Operating Income high stood at $17.3 million for Q3 2025, and its period low was -$10.0 million during Q3 2022.
  • Over the past 3 years, Exponent's median Other Non Operating Income value was $4.8 million (recorded in 2023), while the average stood at $4.6 million.
  • In the last 5 years, Exponent's Other Non Operating Income crashed by 1,646.69% in 2022 and then surged by 913.12% in 2025.
  • Over the past 5 years, Exponent's Other Non Operating Income (Quarterly) stood at $5.3 million in 2021, then surged by 37.17% to $7.2 million in 2022, then skyrocketed by 35.21% to $9.8 million in 2023, then soared by 524.52% to $7.5 million in 2024, then dropped by 3.51% to $7.3 million in 2025.
  • Its last three reported values are $7.3 million in Q4 2025, $17.3 million for Q3 2025, and -$9.4 million during Q2 2025.